
Further, at daily doses of at least 100 mg, the rates of VTE with milvexian were significantly lower than with enoxaparin, according to the study authors.

Further, at daily doses of at least 100 mg, the rates of VTE with milvexian were significantly lower than with enoxaparin, according to the study authors.

The team found that out of more than 18,751 live births, 1008 cancer diagnoses were made in offspring 0 to 58 years of age.




Although specialty therapies have the potential to help people live healthier lives, their cost and complexity can create distinct challenges.

Citracal + D may be used to treat conditions caused by low calcium levels.

Miglustat (Zavesca) is indicated for the treatment of mild to moderate type I Gaucher disease.

Chronic HBV increases the risk of developing liver failure, liver cancer, and cirrhosis.

Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, provides an analysis and overview of key specialty pharmaceuticals in development.

The odds of visiting an ED for anxiety were 2.8 times greater than for non-depressed individuals.

The results of a study show the chance of death for those with cancer taking rituximab was more than double that of medically similar people.

Survey results may imply that individuals who stop could have more health problems or die from a subsequent heart issue.

Lomecel-B (Longeveron) is an investigational allogeneic, bone marrow-derived medicinal signaling cell medication that is being evaluated in a phase 2 trial.

The device is to be worn on the stomach and senses when an individual stops breathing and moving, followed by an injection of naloxone that can restore respiration.


Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses continuing education opportunities for pharmacists to get trained on the proper use and administration of psychedelic drugs.

The VANISH-303 and VANISH-306 studies provide analysis of tablets that treat vulvovaginal candidiasis, which is vaginal yeast infection.

An embryonic stem cell model allowed investigators to study the genetic architecture first in hypothalamic progenitor cells, prior to their full development, and then nucleus-like hypothalamic neurons.


Ron Aung-Din, MD, the clinical medical advisor of Pyscheceutical, and Chad Harman, the CEO of Pyscheceutical, discuss a novel approach for administering psychedelics for the treatment of brain disorders that does not induce hallucinogenic effects.

Growth of telehealth means pharmacists can play an important role in patient care even when working from home.

IVIG also has an important therapeutic role in cases with multisystem inflammatory syndrome in children (MIS-C), the researchers said.

These results are based on a case report of a patient with LCV associated to sensitive neuropathy for whom systemic treatment was ineffective.

The investigators said that this analysis is the most comprehensive assessment of vaccination rates among US hospital personnel to date, using data from 3.3 million HCP.

According to the researchers, almost half of the caregivers surveyed responded that the people they are caring for rely on them more than ever before, with 94% of respondents indicating that they put the needs of the person they care for above their own during the COVID-19 pandemic.

Pharmacists have the potential to make a positive impact by screening patients, providing counseling, encouraging beneficial interventions, and helping tailor patient regimens based on personalized needs.

Diagnosis, treatment options, and the role of the pharmacist in patient care are all important factors when looking at multiple sclerosis as a whole.

Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, discusses key drugs in development that are slated to launch in 2022.

Sotrovimab found not inferior to intravenous administration for the early treatment of mild-to-moderate COVID-19 in high-risk, non-hospitalized patients 12 years of age and older.